Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

April 01, 1988; Volume 33,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Barhanin, J

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;
  2. Beck, W T

    1. You have access
      Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;
  3. Bhatnagar, R K

    1. You have access
      Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;
  4. Binder, T P

    1. You have access
      Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
      T P Binder and M W Duffel
      Molecular Pharmacology April 1988, 33 (4) 477-479;
  5. Bottari, S P

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

C

  1. Chatterjee, T K

    1. You have access
      Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;
  2. Cowan, K H

    1. You have access
      Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
      M E Goldsmith and K H Cowan
      Molecular Pharmacology April 1988, 33 (4) 378-383;
  3. Cox, B M

    1. You have access
      Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;

D

  1. Debing, I

    1. You have access
      Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;
  2. De Matteis, F

    1. You have access
      Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria.
      F De Matteis
      Molecular Pharmacology April 1988, 33 (4) 463-469;
  3. Duffel, M W

    1. You have access
      Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
      T P Binder and M W Duffel
      Molecular Pharmacology April 1988, 33 (4) 477-479;

F

  1. Fisher, S K

    1. You have access
      Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
      S K Fisher
      Molecular Pharmacology April 1988, 33 (4) 414-422;

G

  1. Glazer, R I

    1. You have access
      Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;
  2. Goldberg, I H

    1. You have access
      Role of epoxide in neocarzinostatin chromophore stability and action.
      S H Lee and I H Goldberg
      Molecular Pharmacology April 1988, 33 (4) 396-401;
  3. Goldfien, A

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;
  4. Goldsmith, M E

    1. You have access
      Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
      M E Goldsmith and K H Cowan
      Molecular Pharmacology April 1988, 33 (4) 378-383;
  5. Grant, S

    1. You have access
      Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;

H

  1. Habberfield, A D

    1. You have access
      Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;
  2. Henning, R

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

I

  1. Ijzerman, A P

    1. You have access
      Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;

J

  1. Jacobs, M M

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;
  2. Joost, H G

    1. You have access
      Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

L

  1. Laurenza, A

    1. You have access
      Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;
  2. Lazdunski, M

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;
  3. Lee, S H

    1. You have access
      Role of epoxide in neocarzinostatin chromophore stability and action.
      S H Lee and I H Goldberg
      Molecular Pharmacology April 1988, 33 (4) 396-401;
  4. Lerch, U

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

M

  1. Marie, J

    1. You have access
      Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
      J Marie and C Roy
      Molecular Pharmacology April 1988, 33 (4) 432-440;

O

  1. Oekonomopulos, R

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

P

  1. Parsons, W J

    1. You have access
      The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;
  2. Pearce, H L

    1. You have access
      Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;
  3. Puttfarcken, P S

    1. You have access
      Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;

Q

  1. Qar, J

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

R

  1. Ramkumar, V

    1. You have access
      The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;
  2. Reisine, T

    1. You have access
      Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
      K Thermos and T Reisine
      Molecular Pharmacology April 1988, 33 (4) 370-377;
  3. Riemer, R K

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;
  4. Roberts, J M

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;
  5. Romey, G

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;
  6. Roy, C

    1. You have access
      Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
      J Marie and C Roy
      Molecular Pharmacology April 1988, 33 (4) 432-440;

S

  1. Scott, C E

    1. You have access
      Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;
  2. Seamon, K B

    1. You have access
      Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;
  3. Simpson, I A

    1. You have access
      Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;
  4. Stiles, G L

    1. You have access
      The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;

T

  1. Thermos, K

    1. You have access
      Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
      K Thermos and T Reisine
      Molecular Pharmacology April 1988, 33 (4) 370-377;

U

  1. Urbach, H

    1. You have access
      A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

V

  1. Vauquelin, G

    1. You have access
      Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;
  2. Vazquez, D M

    1. You have access
      Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;

W

  1. Werling, L L

    1. You have access
      Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;
  2. Wu, Y Y

    1. You have access
      Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

Y

  1. Yu, G

    1. You have access
      Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;

Z

  1. Zamora, J M

    1. You have access
      Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 4
1 Apr 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics